INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

D-psicose lowered postprandial blood glucose mainly in borderline diabetes and showed 12-week safety

In a randomized crossover trial of 26 adults including borderline diabetes patients, five grams of D-psicose taken with a meal lowered blood glucose at 30 and 60 minutes (p<0.01, p<0.05) and reduced glucose area under the curve (p<0.01), primarily in borderline diabetes cases. In a 12-week parallel trial of 17 normal subjects taking five grams three times daily, no abnormal effects or clinical problems were observed.

Study type
Randomized controlled trials
Who was studied
26 adults (including borderline diabetes patients) and 17 normal subjects
What was measured
Postprandial blood glucose and clinical safety variables

THE PAPER

Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects.

Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. Biosci Biotechnol Biochem, 2010.

PubMed 20208358 ↗DOI 10.1271/bbb.90707 ↗

Diabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.